MAM
Monaco Asset Management Portfolio holdings
AUM
$269M
1-Year Est. Return
6.08%
1 Year Est. Return
+6.08%
AUM
$264M
AUM Growth
+$66.4M
(+34%)
Holding
107
Top Buys
| 1 | +$15.9M | |
| 2 | +$12.7M | |
| 3 | +$6.5M | |
| 4 |
Capri Holdings
CPRI
|
+$6.38M |
| 5 |
Arvinas
ARVN
|
+$4.31M |
Top Sells
| 1 | +$9.11M | |
| 2 | +$7.23M | |
| 3 | +$2.94M | |
| 4 |
Sprott Physical Silver Trust
PSLV
|
+$2.67M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$2.1M |
Sector Composition
| 1 | Healthcare | 29.02% |
| 2 | Materials | 24.37% |
| 3 | Energy | 15.35% |
| 4 | Communication Services | 13.45% |
| 5 | Consumer Discretionary | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nkarta
NKTX
$133M
| $2.63M | 0.46% |
1,583,372
+770,256
|
|
||
27
QuidelOrtho
QDEL
$1.45B
| $2.31M | 0.4% |
80,000
+35,000
|
|
||
28
Stellantis
STLA
$30B
| $2.26M | 0.4% |
+225,000
|
|
||
29
Heron Therapeutics
HRTX
$202M
| $2.24M | 0.39% |
1,080,000
+120,000
|
|
||
30
Maravai LifeSciences
MRVI
$528M
| $2.12M | 0.37% |
880,965
+45,100
|
|
||
31
Halliburton
HAL
$23B
| $2.04M | 0.36% |
+100,000
|
|
||
|
MAG
32
DELISTED
MAG Silver
MAG
| $2.01M | 0.35% |
95,000
-431,000
|
|
||
33
Valaris
VAL
$3.97B
| $1.89M | 0.33% |
+45,000
|
|
||
34
B2Gold
BTG
$5.48B
| $1.8M | 0.32% |
500,000
|
|
||
|
35
Teva Pharmaceuticals
TEVA
$29.2B
| $1.68M | 0.29% |
100,000
-125,000
|
|
||
36
Ventyx Biosciences
VTYX
$660M
| $1.63M | 0.29% |
761,891
-372,553
|
|
||
37
Bunge Global
BG
$18.6B
| $1.61M | 0.28% |
20,000
+16,889
|
|
||
38
Novavax
NVAX
$1.13B
| $1.45M | 0.25% |
230,000
-60,000
|
|
||
39
Vanda Pharmaceuticals
VNDA
$257M
| $1.44M | 0.25% |
305,000
-20,000
|
|
||
40
Ginkgo Bioworks
DNA
$487M
| $1.41M | 0.25% |
125,000
-52,500
|
|
||
41
Cytokinetics
CYTK
$8.12B
| $1.4M | 0.25% |
+42,500
|
|
||
42
Etsy
ETSY
$5.64B
| $1.25M | 0.22% |
+25,000
|
|
||
43
Inogen
INGN
$187M
| $1.25M | 0.22% |
177,594
+10,000
|
|
||
44
Pan American Silver
PAAS
$16.3B
| $1.15M | 0.2% |
40,468
-254,532
|
|
||
45
Nektar Therapeutics
NKTR
$1.15B
| $1.14M | 0.2% |
43,966
-27,294
|
|
||
46
Intel
INTC
$169B
| $1.12M | 0.2% |
+50,000
|
|
||
47
Rocket Pharmaceuticals
RCKT
$330M
| $1.11M | 0.19% |
+452,767
|
|
||
|
MREO
48
Mereo BioPharma
MREO
$283M
| $1.07M | 0.19% |
395,000
-21,468
|
|
||
|
DVS
49
Dolly Varden Silver Corp
DVS
$375M
| $1.02M | 0.18% |
+305,600
|
|
||
50
Galapagos
GLPG
$2.06B
| $1.01M | 0.18% |
36,036
|
|